George Tachas

457 total citations
14 papers, 313 citations indexed

About

George Tachas is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, George Tachas has authored 14 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in George Tachas's work include Long-Term Effects of COVID-19 (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and RNA Interference and Gene Delivery (2 papers). George Tachas is often cited by papers focused on Long-Term Effects of COVID-19 (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and RNA Interference and Gene Delivery (2 papers). George Tachas collaborates with scholars based in United States, Australia and Germany. George Tachas's co-authors include Gordon Campbell, Julie H. Campbell, John F. Bateman, Mark Diamond, Volker Limmroth, Frederik Barkhof, Shari A. Lofthouse, Christopher J. Wraight, Lavanya Visvabharathy and M. Jane Black and has published in prestigious journals such as PLoS ONE, Neurology and Biochemical Journal.

In The Last Decade

George Tachas

13 papers receiving 310 citations

Peers

George Tachas
Andreas Benn Germany
S. Baydanoff Bulgaria
AM Randi United Kingdom
Joanna Lim Malaysia
Sarah K. Westbury United Kingdom
C. Bijkerk Netherlands
George Tachas
Citations per year, relative to George Tachas George Tachas (= 1×) peers Hoàng Anh Vũ

Countries citing papers authored by George Tachas

Since Specialization
Citations

This map shows the geographic impact of George Tachas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Tachas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Tachas more than expected).

Fields of papers citing papers by George Tachas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Tachas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Tachas. The network helps show where George Tachas may publish in the future.

Co-authorship network of co-authors of George Tachas

This figure shows the co-authorship network connecting the top 25 collaborators of George Tachas. A scholar is included among the top collaborators of George Tachas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Tachas. George Tachas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Koralnik, Igor J., et al.. (2025). Blood diagnostic biomarkers for neurologic manifestations of long COVID. Brain Behavior & Immunity - Health. 49. 101110–101110.
2.
Tachas, George, et al.. (2025). A Novel Combination of Blood Diagnostic Biomarkers Identify Neuro Post-Acute Sequalae of COVID-19 with 90% Accuracy (P1-8.008). Neurology. 104(7_Supplement_1). 1 indexed citations
3.
Visvabharathy, Lavanya, Barbara A. Hanson, Zachary S. Orban, et al.. (2023). Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Frontiers in Immunology. 14. 1155770–1155770. 22 indexed citations
4.
Hanson, Barbara A., Lavanya Visvabharathy, Zachary S. Orban, et al.. (2023). Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behavior and Immunity. 114. 462–474. 16 indexed citations
5.
Visvabharathy, Lavanya, Barbara A. Hanson, Zachary S. Orban, et al.. (2022). Altered T Cell Responses to SARS-CoV-2 Correlate with Neurologic Symptom Severity in Long COVID. SSRN Electronic Journal. 3 indexed citations
6.
Trainer, Peter, John Newell‐Price, John Ayuk, et al.. (2018). A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European Journal of Endocrinology. 179(2). 97–108. 29 indexed citations
7.
Duchartre, Yann, Hye Na Kim, Eun Ji Gang, et al.. (2017). Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies. PLoS ONE. 12(11). e0187684–e0187684. 8 indexed citations
8.
Trainer, Peter, John Newell‐Price, John Ayuk, et al.. (2015). A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly.. Endocrine Abstracts. 3 indexed citations
9.
Limmroth, Volker, et al.. (2014). CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS. Neurology. 83(20). 1780–1788. 45 indexed citations
10.
Wilkinson‐Berka, Jennifer L., et al.. (2007). An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.. PubMed. 13. 1529–38. 19 indexed citations
11.
Tachas, George, Shari A. Lofthouse, Christopher J. Wraight, et al.. (2006). A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice. Journal of Endocrinology. 189(1). 147–154. 23 indexed citations
12.
Campbell, Julie H., et al.. (1990). Molecular biology of vascular hypertrophy. European Journal of Pharmacology. 183(1). 90–90. 19 indexed citations
13.
Tachas, George, et al.. (1990). Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. Biochemical Journal. 265(2). 461–469. 120 indexed citations
14.
Sandrin, Mauro S., et al.. (1987). Gene transfection of the HuLy-m2 (Leu-9) antigen into mouse L cells. Immunogenetics. 25(5). 279–283. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026